Elekta AB (OTCMKTS:EKTAY - Get Free Report)'s share price traded down 1% during trading on Thursday . The company traded as low as $4.91 and last traded at $4.91. 2,585 shares traded hands during mid-day trading, a decline of 67% from the average session volume of 7,817 shares. The stock had previously closed at $4.96.
Analyst Upgrades and Downgrades
Separately, Danske cut Elekta to a "hold" rating in a report on Tuesday, June 3rd.
Check Out Our Latest Report on EKTAY
Elekta Trading Up 0.9%
The stock has a market cap of $1.90 billion, a PE ratio of 99.12 and a beta of 1.22. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.86 and a current ratio of 1.09. The stock has a fifty day moving average price of $5.10 and a 200 day moving average price of $5.40.
Elekta (OTCMKTS:EKTAY - Get Free Report) last announced its earnings results on Wednesday, May 28th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.13 by ($0.02). Elekta had a return on equity of 11.55% and a net margin of 1.15%. The company had revenue of $503.22 million during the quarter, compared to analysts' expectations of $507.19 million. Equities analysts expect that Elekta AB will post 0.36 EPS for the current year.
About Elekta
(
Get Free Report)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
Further Reading
Before you consider Elekta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta wasn't on the list.
While Elekta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
